Real-time enrollment status for this ocular inflammation clinical trial
Current Status
Recruiting
Checked: September 22, 2026 at 2:12 AM UTC
| NCT Number | NCT07831876 |
| Recruiting Status | Recruiting |
| Condition | Ocular Inflammation |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | September 21, 2026 (Yesterday) |
As of September 22, 2026: Clinical trial NCT07831876 is currently recruiting participants. This phase1 study for ocular inflammation is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07831876 is actively recruiting participants as of September 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07831876 was last updated Yesterday (September 21, 2026). HelloStudys verifies this status automatically.